Company / Gross Profit
RIGEL PHARMACEUTICALS INC Gross Profit History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$7.9M
FY2019
5-year range
-
FY2018-FY2019
Trend
+352.3%
vs FY2018
Sector context
#29 of 29
Health Care
What the data says
Among 29 Health Care companies, RIGEL PHARMACEUTICALS INC is in the bottom 0% for gross profit.
Based on SEC 10-K filings.
$8M in FY2019.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 29This company $7.9M Sector average $3.5B
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2019, gross profit increased 352.3% year-over-year.
- Ranks #29 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $7.9M | +352.3% |
| FY2018 | $1.8M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026